The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
Cancer remains as one of the most significant health problems, with approximately 19
million people diagnosed worldwide each year. Chemotherapy is a routinely used method to …
million people diagnosed worldwide each year. Chemotherapy is a routinely used method to …
[HTML][HTML] Macrophages at the interface of the co-evolving cancer ecosystem
DJ Kloosterman, L Akkari - Cell, 2023 - cell.com
Macrophages are versatile and heterogeneous innate immune cells undertaking central
functions in balancing immune responses and tissue repair to maintain homeostasis. This …
functions in balancing immune responses and tissue repair to maintain homeostasis. This …
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
X Li, W Pu, Q Zheng, M Ai, S Chen, Y Peng - Molecular cancer, 2022 - Springer
Proteolysis-targeting chimeras (PROTACs) are engineered techniques for targeted protein
degradation. A bifunctional PROTAC molecule with two covalently-linked ligands recruits …
degradation. A bifunctional PROTAC molecule with two covalently-linked ligands recruits …
Visible-to-NIR-light activated release: from small molecules to nanomaterials
Photoactivatable (alternatively, photoremovable, photoreleasable, or photocleavable)
protecting groups (PPGs), also known as caged or photocaged compounds, are used to …
protecting groups (PPGs), also known as caged or photocaged compounds, are used to …
meso-Methyl BODIPY Photocages: Mechanisms, Photochemical Properties, and Applications
P Shrestha, D Kand, R Weinstain… - Journal of the American …, 2023 - ACS Publications
meso-methyl BODIPY photocages have recently emerged as an exciting new class of
photoremovable protecting groups (PPGs) that release leaving groups upon absorption of …
photoremovable protecting groups (PPGs) that release leaving groups upon absorption of …
PROTACs: an emerging therapeutic modality in precision medicine
DA Nalawansha, CM Crews - Cell chemical biology, 2020 - cell.com
Targeted protein degradation (TPD) has emerged as an exciting new era in chemical
biology and drug discovery. PROteolysis TArgeting Chimera (PROTAC) technology targets …
biology and drug discovery. PROteolysis TArgeting Chimera (PROTAC) technology targets …
An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities
F Annunziata, C Pinna, S Dallavalle… - International Journal of …, 2020 - mdpi.com
Privileged structures have been widely used as an effective template for the research and
discovery of high value chemicals. Coumarin is a simple scaffold widespread in Nature and …
discovery of high value chemicals. Coumarin is a simple scaffold widespread in Nature and …
Taking phototherapeutics from concept to clinical launch
BM Vickerman, EM Zywot, TK Tarrant… - Nature Reviews …, 2021 - nature.com
More than four decades have passed since the first example of a light-activated (caged)
compound was described. In the intervening years, a large number of light-responsive …
compound was described. In the intervening years, a large number of light-responsive …
Photoresponsive molecular tools for emerging applications of light in medicine
IM Welleman, MWH Hoorens, BL Feringa… - Chemical …, 2020 - pubs.rsc.org
Light-based therapeutic and imaging modalities, which emerge in clinical applications, rely
on molecular tools, such as photocleavable protecting groups and photoswitches that …
on molecular tools, such as photocleavable protecting groups and photoswitches that …
Remote light‐responsive nanocarriers for controlled drug delivery: advances and perspectives
Engineering of smart photoactivated nanomaterials for targeted drug delivery systems (DDS)
has recently attracted considerable research interest as light enables precise and accurate …
has recently attracted considerable research interest as light enables precise and accurate …